the trunk appeared (CS 0.95 mgukguday). They spread and evolved into PG-ulcers with clear-cut margins, deep, irregular, violaceous borders and a necrotic centre and showing chronic discharge. These multiple, painful, deep necrotic ulcers (1-3 cm in diameter) covered the trunk and neck (Fig. 1) . Microbiological tests performed on histological sections showed no microorganisms, a finding confirmed by negative cultures. A skin biopsy showed an inflammatory suppurative dermal infiltrate harbouring neutrophils, lymphocytes and histiocytes. IV Ig were continued and CS tapered to 0.4 mgukguday. In February 1998, the skin area affected by PG decreased under treatment with IV Ig and CS (0.25 mgukguday). CS were further tapered (0.2 mgukguday). ANCA and anti-PR3 were no longer detectable. Sinusitis with periorbital oedema recurred in March 1998. A skin biopsy from the border of an ulcer showed intense inflammation of the superficial dermis with multinucleated macrophage-like cells. IV Ig was replaced with azathioprine (2 mgukguday) in May 1998. Five months later, skin lesions had regressed partially. Azathioprine was increased to 2.5 mgukguday but to no avail. Pulmonary nodules, crusted rhinitis and right-sided deafness occurred in April 1999. c-ANCA were detected by immunofluorescence and anti-PR3 by ELISA (66 AU). Azathioprine was stopped, MMF (2 guday orally) was started and the CS dose was increased to 1 mgukguday. For the first time, the PG regressed dramatically; complete healing was obtained within 3 weeks but proved transitory. CS were rapidly tapered (0.5 mgukguday at the end of April). No new lesions appeared over the next 2 months but, when CS reached 0.1 mgukguday at the end of June, small zones of PG reappeared on the left shoulder. This relapse was controlled by increasing prednisone to 0.15 mgukguday and MMF to 3 guday. No side-effects of MMF were noted. WG was then in remission, with only minor zones of PG on the left shoulder; c-ANCA and anti-PR3 levels were also stable.
Although skin involvement has been observed in 14-47% of patients with WG [1] [2] [3] [4] , pyoderma-like ulcers or necrotizing ulcerations resembling PG are rare manifestations [5] [6] [7] [8] . Cutaneous involvement may occur during the course of the disease or be present at onset [5] [6] [7] and may develop on unusual sites, e.g. the trunk [8] , neck [5] and face [6] , and may indicate an exacerbation of existing WG. Our case is unusual because cutaneous lesions became the predominant symptom, surpassing sinusitis and pulmonary signs at the time of the second relapse, and because of their persistence and spread despite appropriate treatment, including CS, IV Ig and azathioprine. Nowack et al. [9] were the first to report the successful use of MMF, as maintenance therapy after standard induction therapy, in 10 systemic WG patients, of whom four showed skin involvement. They also successfully prescribed MMF as induction treatment to replace CYC in a WG patient [9] . We used MMF because of its strong immunosuppressive effect and lymphocyteselective mode of action and because it has few sideeffects. As illustrated here, alternative treatments to high-dose CS combined with CYC, azathioprine or high-dose IV Ig anduor new drugs should be attempted in the therapeutic strategy of refractory ANCA-related vasculitides. Correspondence to: C. Le Hello.
